RecallRadar

FDA Drug recall D-1826-2019

Clear Eyes Assorted IRC Display

On 2019-08-28 the FDA classified a Class II recall of Clear Eyes Assorted IRC Display by Medtech Products, citing CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the….

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1826-2019
ClassificationClass II
Statusterminated
Initiated2019-07-26
Published2019-08-28
Last updated2026-09-13 11:52 UTC
CompanyMedtech Products
DistributionUS

Product

Clear Eyes Assorted IRC Display; each display contains 6 each of a) Clear eyes REDNESS RELIEF (Glycerin 0.25%, Naphazoline hydrochloride 0.12%) eye drops, 0.5 FL OZ (15 mL) bottle (UPC 6 78112 25415 6); b) Clear eyes MAXIMUM REDNESS RELIEF (Glycerin 0.5%, Naphazoline hydrochloride 0.03%), 0.5 FL OZ (15 mL) bottle (UPC 6 78112 66577 8); and c) Clear eyes MAXIMUM ITCHY EYE RELIEF (Glycerin 0.25%, Naphazoline hydrochloride 0.012%, Zinc Sulfate 0.25%), 0.5 FL OZ (15 mL) bottle (UPC 6 78112 65920 3); Distributed by Medtech Products Inc., Tarrytown, NY 10591, A Prestige Brands Company, display UPC 6 78112 10452 9.

Reason

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Identifiers

upc678112254156
upc678112665778
upc678112659203
upc678112104529
code_infoLot #: Display 17E23A, Exp 12/19; lot and expiry for individual products within this display are captured in each individual product Code Information

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1826-2019%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.